Scottsdale Interventional Forum (SIF) 2025

Name: Scottsdale Interventional Forum (SIF) 2025 | MedicalAmboss
SKU: MED-AMB07938
Price: 20.00 USD
Availability: InStock

$20.00

Recommended medical resources for your specialty.

Scottsdale Interventional Forum (SIF) 2025

$20.00

Mayo Clinic Echocardiography Board Review Course 2026 (Videos+Slides)

1 × Mayo Clinic Echocardiography Board Review Course 2026 (Videos+Slides)

$155.00

Continuing Education Company 28th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2024

1 × Continuing Education Company 28th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2024

$40.00

Harvard Innovations and New Practices in Internal Medicine 2026

1 × Harvard Innovations and New Practices in Internal Medicine 2026

$150.00

Aging Immune Function and Organ Health 2026 (Videos + PDFs)

1 × Aging Immune Function and Organ Health 2026 (Videos + PDFs)

$70.00

Carefully selected courses and references to support your clinical practice.

SKU: MED-AMB07938 Categories: Critical Care - Emergency medicine, Cardiology, Internal Medicine

Description

Videos Only

Overview
Scottsdale Interventional Forum (SIF) 2025 This symposium is designed to equip participants with the practical skills needed to enhance bedside patient management, apply innovative therapies effectively, and improve outcomes for patients with cardiovascular disease.

Target Audience
This activity is intended for physicians, nurses, and allied health professionals seeking a comprehensive, up-to-date review of disease mechanisms, diagnostic imaging, and expert management strategies for advanced cardiovascular disorders.

Learning Objectives
By the end of this activity, participants should be able to:

Explain the role of mechanical circulatory support in patients undergoing complex coronary intervention.
Discuss novel stent platforms and the regulatory pathway to FDA approval.
Develop a practical understanding of newer methods for plaque and calcium modification in coronary disease management.
Compare surgical and percutaneous revascularization approaches in diabetic patients with complex coronary anatomy.
Discuss the role of advanced imaging in cardiovascular disease management, including noninvasive imaging and high-resolution invasive coronary imaging such as OCT and IVUS.
Describe the emerging role of mechanical left atrial appendage therapy, novel cerebral embolic protection devices, and adjunctive devices in structural heart disease management.
Apply knowledge of radial-based and alternative vascular access approaches in cardiovascular therapy.
Define the role of transcatheter and surgical therapies for patients with advanced aortic stenosis and aortic insufficiency.
Discuss the role of transcatheter aortic valve replacement (TAVR) in patients with symptomatic moderate aortic stenosis.
Describe catheter-based therapies for degenerative and functional mitral valve disease.
Define emerging therapies for tricuspid and pulmonic valve disease.
Review the most relevant clinical trials in coronary and structural heart disease that are shaping the near future of patient management.
Review the most important recent trials in antiplatelet and antithrombotic therapy.

S. No.	Title	Run Time
1	RCA ISR Management: Stent Boost and IVUS Inform DES Over DCB in Elderly Patient	43:51
2	Severe Valvular and Left Main CAD in Frail Patient: DK Crush PCI Strategy and Impella Support	43:52
3	Aortic Valve-in-Valve in Lotus Prosthesis: Technical Challenges and Key Lessons	53:48
4	Chronic Total Occlusion in RCA With Severe Obesity: Retrograde PCI Strategy and IVUS Guidance	36:34
5	Valve-in-Valve in Bicuspid AVR With Dacron Graft: Managing Fracture Limitations	22:59
6	CTO in RCA With Persistent Angina: Dual Guide Approach, IVUS Imaging, and Stenting	39:37
7	Presentation of a Case: Concomitant AF Ablation and LAA Occlusion	36:38
8	Severe MR in a 71-Year-Old: Valve-in-Valve-in-Ring Approach and Deployment Challenges	15:07
9	Women’s Heart Disease: Key Symptom Patterns and Early Detection	07:51
10	Examples of Escalating MCS in STEMI	10:35
11	Mechanical Complications of MI with Cardiogenic Shock: MitraClip Rescue	08:58
12	Vascular Access Challenges with MCS	10:00
13	Cut, Laser, Drill, and Shock	15:28
14	Massive Coronary Thrombosis- Treatment Algorithm and Creative Approaches	16:18
15	The Most Difficult Bifurcations- A Step-by-Step Algorithm	15:32
16	Approaches to Treating Complex Vein Graft Lesions (and the Native Vessels They Supply)	14:57
17	Mitral Transcatheter Edge-to-Edge Repair and Mandatory Mechanical Circulatory Support in Patients with Structural Shock	13:19
18	Novel Use of MitraClip to Treat Aortic Regurgitation	08:52
19	Intravascular Imaging is Now Class 1A in the European Guidelines: How Should US Interventionalists Respond?	22:43
20	Leaflet and Septal Modification during VIV TMVR: Rationale, Tips, and Tricks	15:28
21	Patient Selectiong for Tricuspid Therapies	09:35
22	Optimal TEE and 3D-ICE for Efficient and Effective T-TEER and TTVR	11:00
23	Transcatheter Mitral and Tricuspid Valve in Valve Best Practices	10:57
24	The Next Pillar of Heart Failure Management – the GLP-1 Agonist Phenomenon	13:51
25	Aortic Stenosis and Coronary Artery Disease: A Case Presentation	11:07
26	Coronary Evaluation and Stenting Pre-TAVR: Neither Cath nor PCI Frequently Necessary	08:37
27	Echo Gradients Are Flawed: All BE and SE Valves Do Well!	08:26
28	The Transcatheter Valve Journey: Present and Future	12:56
29	TAV-in-SAV and TAV-in-TAV: ABCDs of the Pre-Procedural Evaluation	13:01
30	Pre TAVR: Cath and Aggressive PCI for All?	11:59
31	The Data Are Clear: Self-Expanding Superior in Smaller Valves	11:35
32	Catheter Based Treatment for Valvular Heart Disease	03:44
33	Advances in Coronary Artery Disease Management	07:28
34	The Growing Field of Heart Failure Management	10:49
35	EVOQUE Tricuspid Valve Replacement	10:38
36	Strategies to Prevent Heart Disease	05:45
37	Managing Stable CAD in Severe Aortic Stenosis: Insights from NOTION and PCI Strategies	12:04
38	Mean Gradient with TEER: Why Higher Gradients Should be Tolerated	10:37
39	Optimal Pharmacologic Management Following LAAO	09:29
40	Left Atrial Appendage Occlusion: Current Advances, Remaining Challenges	10:15
41	M-TEER for Functional MR	13:59
42	Putting LAAO Clinical Trials in Perspective	10:34
43	How to Treat This 75-Year-Old with Severe Degenerative MR	02:10
44	Catheter-Based Therapies for Managing Aortic Insufficiencies	22:27
45	Spare the Blade – M-TEER Today!	04:50
46	The Data Are Favorable, but Can T-TEER Be Democratized?	12:37
47	Mitral Debate – No Way – Surgical Repair Rules Today!	11:58
48	Understanding FDA T-TEER Trials: Are There Enough Pros?	16:03
49	The Role of Transcatheter Tricuspid Valve Replacement: Unsuccessful TTEER with Giant Coaptaion Gap	10:27
50	CT Guidance in TMVR: Lessons Learned and Evolving Imaging Protocols	13:14
51	Tricuspid Regurgitation Impact on TAVR and M-TEER	10:35
52	Transcatheter Repair versus Mitral Valve Surgery for Secondary Mitral Regurgitation – Challenges in Trial Design and Interpretation of Outcomes	10:00
53	Should There Be Sex-Based Considerations in the Care of the AS Patient?	13:11
54	Will T-TEER Evolve Similar to M-TEER: an Operator’s Perpsective	11:27
55	Upstream Treatment of AS: Early TAVR, Evolved, TAVR Unload	19:37
56	Back to the Basics: Are Exercise Right Heart Catheterizations Mandatory?	05:37
57	CVD Jeopardy: Cath Lab & ICU Essentials – Arrhythmias, Shock, and Dissection Anticoagulation Pitfalls	17:30
58	The Evolution of HFrEF Therapies	13:52
59	The Emerging Role of Transcatheter Shunts	10:01
60	Evidence-Based Interventions Targeting Valvular Heart Disease in Heart Failure	15:13
61	ModulHeart, Aortix and the Novel Support Devices for Heart Management	15:08
62	Mea Culpa, Mea Culpa, Mea Maxima Culpa – STEMI Management	13:11
63	Left Atrial–Coronary Sinus Shunt Case: Salvaging a Disaster	11:50
64	The Heartbreak of Substance Use	15:23
65	Contemporary Management of STEMI/SHOCK	14:35
66	Cardiac Biomarkers in Acute and Chronic Care	13:17
67	Spontaneous Coronary Artery Dissection: Women & Heart Disease	14:18
68	Equipoise – What’s That – We Did That Study Already	11:07
69	Structural Heart Disease – Evaluation, Management and Postop Care	15:11
70	Transcatheter Repair versus Mitral Valve Surgery for Secondary Mitral Regurgitation	VIDEO
71	Cryptogenic Stroke: What’s a PFO?	08:37
72	Surgical vs Transcatheter Approaches in Functional Mitral Regurgitation: Short and Long-Term Data	06:25
73	Failure to Cross: Success Begins with Failure	15:16
74	Left Main Disease: Management Challenges and PCI vs CABG Decision-Making	10:22
75	Making the Cath Lab a Safer Environment: Advances in Radiation Safety	12:55
76	Top Coronary Trials of the Last Year – 2025 Update	14:09
77	Oh, How I Wish That Wouldn’t Have Happened	19:03
78	Will There Be New Indications for the Use of DCB in Coronary Intervention?	13:22
79	CCTA in 2025 – Planning PCI	11:26
80	AMI With Cardiogenic Shock and RV Failure: Escalating to ECMO for Hemodynamic Rescue	02:55
81	Comprehensive Invasive Physiology Suite: From Diagnosis to Outcomes	10:20
82	STEMI vs. Cardiogenic Shock: Understanding the Data on Complete vs. Culprit-Only PCI	13:07
83	Expanding Indication for Intravascular Lithotripsy	14:50
84	Restore EF, Protect III, Protect IV: Where Is the Data Leading?	09:00
85	Shock Outcomes in 2024: Review of Recent Data and Where to Go from There	14:45
86	Acute Cardiogenic Shock Management	10:17
87	STEMI Management: Unloading Before Revascularization – Clinical Implications	10:53
88	Elective Multivessel CAD and the Evidence for Complete Revascularization	09:50